The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Interactions Between the Intestinal Microbiome and Liver Diseases
Open accessAbstract
The human intestine harbors a diverse community of microbes that promote metabolism and digestion in their symbiotic relationship with the host. Disturbance of its homeostasis can result in disease. We review factors that disrupt intestinal homeostasis and contribute to nonalcoholic fatty liver disease, steatohepatitis, alcoholic liver disease, and cirrhosis. Liver disease has long been associated with qualitative and quantitative (overgrowth) dysbiotic changes in the intestinal microbiota. Extrinsic factors, such as the Western diet and alcohol, contribute to these changes. Dysbiosis results in intestinal inflammation, a breakdown of the intestinal barrier, and translocation of microbial products in animal models. However, the contribution of the intestinal microbiome to liver disease goes beyond simple translocation of bacterial products that promote hepatic injury and inflammation. Microbial metabolites produced in a dysbiotic intestinal environment and host factors are equally important in the pathogenesis of liver disease. We review how the combination of liver insult and disruptions in intestinal homeostasis contribute to liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the impact of changes to the composition and function of the microbiome in NASH include altered bile acid metabolism and loss of integrity of the gut-vascular barrier, precipitating leakage of LPS and bacteria into the liver via the portal circulation (14–16).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [14]
In the citing paper
“Changes in gut microbiota (dysbiosis) may play a key role in the pathogenesis of NAFLD/NASH and cholestasis52–54 and may also impact on BA composition and signalling.51 55”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [54]
In the citing paper
“However, a failing gut barrier and alterations of the gut microbiota in chronic liver disease (CLD) contribute to chronic inflammation and the progression of liver diseases12, and thereby increase risk for the development of hepatocellular carcinoma (HCC) as the final stage of the disease process 13–15.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [12]
In the citing paper
“Metagenomic studies have revealed substantial alterations in the composition of the gut microbiota in a range of CLD as well as in patients with cirrhosis12,32.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 974
The gut microbiome and aquatic toxicology: An emerging concept for environmental health
Adamovský, O., Buerger, A. N., Wormington, A. M., Ector, N., Griffitt, R. J., Bisesi, J. H., & Martyniuk, C. J. (2018) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4249 · Cited by 165
Lipopolysaccharide and the gut microbiota: considering structural variation
Mohr, A. E., Crawford, M. S., Jasbi, P., Fessler, S. N., & Sweazea, K. L. (2022) · FEBS Letters · doi:10.1002/1873-3468.14328 · Cited by 165
Nonalcoholic Fatty Liver Disease in Children
Mann, J. P., Valenti, L. V. C., Scorletti, E., Byrne, C. D., & Nobili, V. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1627456 · Cited by 169
Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
Iacob, S. A., & Iacob, D. G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01676 · Cited by 158
Non-alcoholic Fatty Liver Disease: A Clinical Update
Pappachan, J. M., Babu, S. V., Krishnan, B., & Ravindran, N. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00013 · Cited by 166
Bile acids and the metabolic syndrome
McGlone, E. R., & Bloom, S. R. (2018) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563218817798 · Cited by 157
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Fukui, H. (2019) · Diseases · doi:10.3390/diseases7040058 · Cited by 159
Liver–Microbiome Axis in Health and Disease
Adolph, T. E., Grander, C., Moschen, A. R., & Tilg, H. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.05.002 · Cited by 167
The features of mucosa‐associated microbiota in primary sclerosing cholangitis
Torres, J., Bao, X., Goel, A., Colombel, J. ‐., Pekow, J., Jabri, B., Williams, K. M., Castillo, A., Odin, J. A., Meckel, K., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13552 · Cited by 149
Gut microbiota and host metabolism in liver cirrhosis
Usami, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11597 · Cited by 152
Importance of Kupffer Cells in the Development of Acute Liver Injuries in Mice
Tsutsui, H., & Nishiguchi, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057711 · Cited by 151
A potential role for the gut microbiome in substance use disorders
Meckel, K. R., & Kiraly, D. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05232-0 · Cited by 146
Low‐grade endotoxemia and platelet activation in cirrhosis
Raparelli, V., Basili, S., Carnevale, R., Napoleone, L., Del Ben, M., Nocella, C., Bartimoccia, S., Lucidi, C., Talerico, G., Riggio, O., et al. (2017) · Hepatology · doi:10.1002/hep.28853 · Cited by 142
Wang, Y., Tiruthani, K., Li, S., Hu, M., Zhong, G., Tang, Y., Roy, S., Zhang, L., Tan, J. H., Liao, C., et al. (2021) · Advanced Materials · doi:10.1002/adma.202007603 · Cited by 145
Meroni, M., Longo, M., & Dongiovanni, P. (2019) · Nutrients · doi:10.3390/nu11112642 · Cited by 152
Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights
Greuter, T., & Shah, V. H. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1190-4 · Cited by 142
García‐Lezana, T., Raurell, I., Bravo, M., Torres‐Arauz, M., Salcedo, M. T., Santiago, A., Schoenenberger, A., Manichanh, C., Genescà, J., Martell, M., et al. (2018) · Hepatology · doi:10.1002/hep.29646 · Cited by 136
Leaky gut – concept or clinical entity?
Quigley, E. M. M. (2016) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000243 · Cited by 139
Duarte, S. M. B., Stefano, J. T., Miele, L., Ponziani, F. R., de Souza-Basqueira, M., Okada, L. S. R. R., Costa, F., Toda, K., Mazo, D. F. D. C., Sabino, É. C., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.014 · Cited by 139
Grønbæk, H., Rødgaard‐Hansen, S., Aagaard, N. K., Arroyo, V., Moestrup, S. K., García, E., Solà, E., Domenicali, M., Piano, S. S., Vilstrup, H., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.021 · Cited by 136
Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis
Schneditz, G., Rentner, J., Roier, S., Pletz, J., Herzog, K. A. T., Bücker, R., Troeger, H., Schild, S., Weber, H., Breinbauer, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403274111 · Cited by 137
Role of Gut Microbiota in Hepatocarcinogenesis
Gupta, H., Youn, G. S., Shin, M. J., & Suk, K. T. (2019) · Microorganisms · doi:10.3390/microorganisms7050121 · Cited by 134
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease
Suk, K. T., & Kim, D. J. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1569513 · Cited by 139
Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
Boursier, J., & Diehl, A. M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004559 · Cited by 140
Dysbiosis of gut microbiota in patients with esophageal cancer
Deng, Y., Tang, D., Hou, P., Shen, W., Li, H., Wang, T., & Liu, R. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104709 · Cited by 133
Gut Microbiome Toxicity: Connecting the Environment and Gut Microbiome-Associated Diseases
Tu, P., Chi, L., Bodnar, W. M., Zhang, Z., Gao, B., Bian, X., Stewart, J. R., Fry, R. C., & Lü, K. (2020) · Toxics · doi:10.3390/toxics8010019 · Cited by 136
Canesso, M. C. C., Lacerda‐Queiroz, N., Cm, F., Gonçalves, J. L., de Almeida, D. L., Gamba, C. D. O., Cassali, G. D., Pedroso, S. H., Moreira, C. F., Martins, F. S., et al. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0240-4 · Cited by 127
Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma
Lu, H., Ren, Z., Li, A., Zhang, H., Jiang, J., Xu, S., Luo, Q., Zhou, K., Sun, X., Zheng, S., et al. (2016) · Scientific Reports · doi:10.1038/srep33142 · Cited by 129
Alcoholic liver disease: A current molecular and clinical perspective
Ohashi, K., Pimienta, M., & Seki, E. (2018) · Liver Research · doi:10.1016/j.livres.2018.11.002 · Cited by 133
Ding, Y., Yanagi, K., Cheng, C., Alaniz, R. C., Lee, K., & Jayaraman, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.029 · Cited by 125
Hu, J., Luo, H., Wang, J., Tang, W., Lu, J., Wu, S., Xiong, Z., Yang, G., Chen, Z., Lan, T., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.122 · Cited by 126
Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
Takaki, A., Kawai, D., & Yamamoto, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057352 · Cited by 127
Chen, Z., Zhou, D., Han, S., Zhou, S., & Jia, G. (2019) · Particle and Fibre Toxicology · doi:10.1186/s12989-019-0332-2 · Cited by 126
The Role of the Gut Microbiome in Liver Cirrhosis Treatment
Lee, N. Y., & Suk, K. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010199 · Cited by 131
Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease
Hannah, W. N., & Harrison, S. A. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4153-y · Cited by 129
Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut–Liver Axis
Bajaj, J. S., Kakiyama, G., Zhao, D., Takei, H., Fagan, A., Hylemon, P. B., Zhou, H., Pandak, W. M., Nittono, H., Fiehn, O., et al. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13498 · Cited by 126
Stärkel, P., Leclercq, S., de Timary, P., & Schnabl, B. (2018) · Clinical Science · doi:10.1042/cs20171055 · Cited by 127
Self-citationKhan, A., Ding, Z., Ishaq, M. H., Bacha, A. S., KHAN, I. A., Hanif, A., Li, W., & Guo, X. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56214 · Cited by 130
Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy
Wan, M. L. Y., & El-Nezami, H. S. (2018) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2017.12.07 · Cited by 120
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.073 · Cited by 123
Zhang, Z., Ran, C., Ding, Q., Liu, H.-L., Xie, M., Yang, Y., Xie, Y.-D., Gao, C., Zhang, H., & Zhou, Z. (2019) · Communications Biology · doi:10.1038/s42003-019-0526-z · Cited by 118
Schneider, K. M., Bieghs, V., Heymann, F., Hu, W., Yildiz, D., Liao, L., Frissen, M., Ludwig, A., Gaßler, N., Pabst, O., et al. (2015) · Hepatology · doi:10.1002/hep.27982 · Cited by 112
Lowe, P., Gyöngyösi, B., Satishchandran, A., Iracheta‐Vellve, A., Ambade, A., Kodys, K., Catalano, D., Ward, D. V., & Szabó, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174544 · Cited by 119
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases
Fabris, L., Fiorotto, R., Spirlì, C., Cadamuro, M., Mariotti, V., Perugorria, M. J., Bañales, J. M., & Strazzabosco, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0156-4 · Cited by 116
Role of farnesoid X receptor and bile acids in alcoholic liver disease
Manley, S., & Ding, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.12.011 · Cited by 116
Gut-liver axis signaling in portal hypertension
Simbrunner, B., Mandorfer, M., Trauner, M., & Reiberger, T. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i39.5897 · Cited by 113
Microbiota Protects Mice Against Acute Alcohol‐Induced Liver Injury
Chen, P., Miyamoto, Y., Mazagova, M., Lee, K., Eckmann, L., & Schnabl, B. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12900 · Cited by 111
Self-citationCollins, F. L., Irwin, R., Bierhalter, H., Schepper, J. D., Britton, R. A., Parameswaran, N., & McCabe, L. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153180 · Cited by 112
Binge Drinking's Effects on the Body
Molina, P. E. (2018) · Alcohol research · doi:10.35946/arcr.v39.1.13 · Cited by 108
Amornphimoltham, P., Yuen, P. S. T., Star, R. A., & Leelahavanichkul, A. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05581-y · Cited by 109
Kim, S. J., Kim, S., Kim, A.-R., Kang, S.-Y., Park, M.-Y., & Sung, M. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1557-9 · Cited by 109
Zisser, A., Ipsen, D. H., & Tveden‐Nyborg, P. (2021) · Biomedicines · doi:10.3390/biomedicines9040365 · Cited by 112
The Gut Microbiome in Health and Disease
Owyang, C., & Wu, G. D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.032 · Cited by 118
Lv, X., Wu, Q., Cao, Y.-J., Lin, Y., Guo, W., Rao, P., Zhang, Y., Chen, Y., Ai, L., & Ni, L. (2022) · Food & Function · doi:10.1039/d1fo03219d · Cited by 105
Korpela, K., Mutanen, A., Salonen, A., Savilahti, E., de Vos, W. M., & Pakarinen, M. P. (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115584388 · Cited by 108
Gut microbiome and liver disease
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.005 · Cited by 106
Ling, Z., Liu, X., Cheng, Y., Jiang, X., Jiang, H., Wang, Y., & Li, L. (2015) · Scientific Reports · doi:10.1038/srep17098 · Cited by 103
Evaluation of Prebiotic Potential of Three Marine Algae Oligosaccharides from Enzymatic Hydrolysis
Han, Z., Yang, M., Fu, X., Chen, M., Su, Q., Zhao, Y., & Mou, H. (2019) · Marine Drugs · doi:10.3390/md17030173 · Cited by 106
Nash, M. J., Frank, D. N., & Friedman, J. E. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00349 · Cited by 101
Akkermansia muciniphila plays critical roles in host health
Zhao, Q., Yu, J., Hao, Y., Zhou, H., Hu, Y., Zhang, C., Zheng, H., Wang, X., Zeng, F., Hu, J., et al. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2037506 · Cited by 102
Gut–liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice
Wang, X., Fang, Y., Liang, W., Cai, Y., Wong, C. C., Wang, J., Wang, N., Lau, H. C.-H., Jiao, Y., Zhou, X., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-024-01890-9 · Cited by 113
Cho, Y.-E., Yu, L.-R., Abdelmegeed, M. A., Yoo, S.-H., & Song, B.-J. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.02.005 · Cited by 99
Gut Microbiota and Lifestyle Interventions in NAFLD
Houghton, D., Stewart, C. J., Day, C. P., & Trenell, M. I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040447 · Cited by 99
Severe Gut Microbiota Dysbiosis Is Associated With Poor Growth in Patients With Short Bowel Syndrome
Piper, H. G., Fan, D., Coughlin, L. A., Ho, E. X., McDaniel, M. M., Channabasappa, N., Kim, J., Kim, M., Zhan, X., Xie, Y., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607116658762 · Cited by 98
Oñate, F. P., Chamignon, C., Burz, S. D., Lapaque, N., Monnoye, M., Philippe, C., Bredel, M., Chêne, L., Farin, W., Paillarse, J.-M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512232 · Cited by 97
Gut Microbiota and Complications of Liver Disease
Acharya, C., & Bajaj, J. S. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.013 · Cited by 101
Medications for alcohol use disorders: An overview
Akbar, M. D., Egli, M., Cho, Y., Song, B., & Noronha, A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.007 · Cited by 101
Mathews, S., Feng, D., Maricic, I., Ju, C., Kumar, V., & Gao, B. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.06 · Cited by 96
Wankhade, U. D., Zhong, Y., Kang, P., Alfaro, M., Chintapalli, S. V., Piccolo, B. D., Mercer, K. E., Andres, A., Thakali, K. M., & Shankar, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-34453-0 · Cited by 100
Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
Porras, D., Nistal, E., Martínez‐Flórez, S., González‐Gallego, J., García‐Mediavilla, M. V., & Sánchez‐Campos, S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01813 · Cited by 97
Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice
Li, R., Li, J., Huang, Y., Li, H., Yan, S., Lin, J., Chen, Y., Wu, L., Liu, B., Wang, G., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.26086 · Cited by 94
Chashmniam, S., Mirhafez, S. R., Dehabeh, M., Hariri, M., Azimi–Nezhad, M., & Gh, B. F. N. M. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0386-5 · Cited by 94
In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations
Lee, Y., & Seki, E. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.05.010 · Cited by 102
Yun, Y., Kim, H.-N., Lee, E., Ryu, S., Chang, Y., Shin, H. C., Kim, H., Kim, T. H., Yoo, K., & Kim, H. Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213692 · Cited by 97
Wu, T. H., Xu, F., Su, C., Li, H., Lv, N., Liu, Y., Gao, Y., Lan, Y., & Li, J.-B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01331 · Cited by 96
Tsai, M., Liu, Y.-Y., Lin, C., Wang, C., Wu, Y., Yong, C., Chen, K., Chuah, S., Yao, C., Huang, P., et al. (2020) · Nutrients · doi:10.3390/nu12030820 · Cited by 96
Marlicz, W., Łoniewski, I., Grimes, D. S., & Quigley, E. M. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.07.015 · Cited by 91
6-Gingerol ameliorates sepsis-induced liver injury through the Nrf2 pathway
Hong, M., Hu, L., Zhang, Y.-X., Xu, Y., Liu, X., He, P., & Jia, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106196 · Cited by 90
Yoon, S. J., Yu, J. S., Min, B. H., Gupta, H., Won, S., Park, H., Han, S. H., Kim, B., Kim, K. H., Kim, B. K., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1129904 · Cited by 92
Nonalcoholic Fatty Liver Disease and the Gut Microbiome
Boursier, J., & Diehl, A. M. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.012 · Cited by 93
Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy
Mancini, A., Campagna, F., Amodio, P., & Tuohy, K. M. (2018) · Food & Function · doi:10.1039/c7fo01528c · Cited by 89
Microbiota and gastrointestinal cancer
Weng, M., Chiu, Y., Wei, P., Chiang, C.-W., Fang, H., & Wei, S. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.01.002 · Cited by 91
Microbiome diurnal rhythmicity and its impact on host physiology and disease risk
Nobs, S. P., Tuganbaev, T., & Elinav, E. (2019) · EMBO Reports · doi:10.15252/embr.201847129 · Cited by 91
Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma
Cho, E. J., Leem, S., Kim, S. A., Yang, J., Lee, Y. B., Kim, S. S., Cheong, J. Y., Cho, S. W., Kim, J. W., Kim, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44012-w · Cited by 94
Joshi‐Barve, S., Kirpich, I., Cave, M. C., Marsano, L. S., & McClain, C. J. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.05.006 · Cited by 93
Hamid, H., Zhang, J. Y., Li, W. X., Liu, C., Li, M., Zhao, L. H., Ji, C., & Ma, Q. G. (2019) · Poultry Science · doi:10.3382/ps/pey596 · Cited by 90
Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis
Jiang, J., Chen, X., Ren, Z., & Zheng, S. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.11.002 · Cited by 100
Chen, M., Hui, S., Lang, H., Zhou, M., Zhang, Y., Kang, C., Zeng, X., Zhang, Q., Yi, L., & Mi, M. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800612 · Cited by 85
Dai, X., Guo, Z., Chen, D., Li, L., Song, X., Liu, T., Jin, G., Li, Y., Liu, Y., Ajiguli, A., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1738187 · Cited by 89
Pathak, P., Helsley, R. N., Brown, A. L., Buffa, J. A., Choucair, I., Nemet, I., Baleanu‐Gogonea, C., Gogonea, V., Wang, Z., Garcı́a-Garcı́a, J. C., et al. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00584.2019 · Cited by 89
Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
Bibbò, S., Ianiro, G., Dore, M. P., Simonelli, C., Newton, E. E., & Cammarota, G. (2018) · Mediators of Inflammation · doi:10.1155/2018/9321643 · Cited by 88
Nie, Y., Liu, Q., Zhang, W., Wan, Y., Huang, C., & Zhu, X. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1972746 · Cited by 88
Gut microbiota, fatty liver disease, and hepatocellular carcinoma
Chu, H., Williams, B., & Schnabl, B. (2018) · Liver Research · doi:10.1016/j.livres.2017.11.005 · Cited by 84
Self-citationEnvironmental Influences in the Etiology of Colorectal Cancer: the Premise of Metabolomics
Rattray, N. J. W., Charkoftaki, G., Rattray, Z., Hansen, J. E., Vasiliou, V., & Johnson, C. H. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0088-z · Cited by 90
Oh, J. K., Vasquez, R., Kim, S., Hwang, I., Song, J. H., Park, J. H., Kim, I. H., & Kang, D. (2021) · Journal of Animal Science and Technology · doi:10.5187/jast.2021.e94 · Cited by 85
Periodontitis is associated with incident chronic liver disease—A population‐based cohort study
Helenius‐Hietala, J., Suominen, A. L., Ruokonen, H., Knuuttila, M. L. E., Puukka, P. J., Jula, A., Meurman, J. H., & Åberg, F. O. (2018) · Liver International · doi:10.1111/liv.13985 · Cited by 87
Gu, F., Zhu, S., Hou, J., Tang, Y., Liu, J., Xu, Q., & Sun, H. (2023) · Microbiome · doi:10.1186/s40168-023-01535-9 · Cited by 88
Utzeri, E., & Usai, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i22.3954 · Cited by 86
Choi, Y., Abdelmegeed, M. A., & Song, B. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.11.011 · Cited by 83
Terciolo, C., Dapoigny, M. C., & André, F. (2019) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s181590 · Cited by 94
Metadata
- Authors
- Schnabl, B., & Brenner, D. A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Schnabl, Bernd
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 146
- Issue
- 6
- Pages
- 1513-1524
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC3996054
- OpenAlex
- W1975691929
- Cited by
- 971
- References
- 86
- Citations by year
- 2026: 37 · 2025: 56 · 2024: 88 · 2023: 101 · 2022: 88 · 2021: 92 · 2020: 102 · 2019: 88 · 2018: 89 · 2017: 58 · 2016: 64 · 2015: 77 · 2014: 31
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (U01 AA021856, R01 AA020703, 2 P42 ES010337, K08 DK081830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- gut microbiota, gut-liver axis, non-alcoholic fatty liver disease, steatohepatitis, alcoholic liver disease, liver cirrhosis, dysbiosis, intestinal homeostasis, intestinal barrier dysfunction, intestinal inflammation, microbial translocation, microbial metabolites, Western diet, alcohol
- MeSH terms
- Animals, Bacteria, Bile Acids and Salts, Fatty Liver, Humans, Intestines, Liver Cirrhosis, Liver Diseases, Liver Diseases, Alcoholic, Risk Factors, Host-Pathogen Interactions, Microbiota, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
